Experiences with
Chemotherapy17,743 public posts
Want to take advantage of all our features? Just log in!
or
FDA Approves Imfinzi (durvalumab) as First-Line Therapy for Limited-Stage SCLC
Previously approved in combination with chemotherapy for untreated extensive-stage small cell lung cancer (ES-SCLC), Imfinzi (durvalumab) is an immunotherapy medication that blocks the PD-L1 protein on cancer cells.